扩大获得药物的机会:一个现实的审查
Emma Bartle1, Sandra E Carr1, Rebecca Olson2
1Health Professions Education, School of Health and Clinical Sciences, The University of Western Australia, Crawley, WA, Australia.
Medical education
|August 8, 2025
概括
扩大进入医学院的机会需要解决系统性障碍,而不仅仅是个人申请者的挑战. 目前的干预措施往往集中在申请者身上,加强现状,限制医学教育中的多样性.
科学领域:
- 医学教育 医学教育
- 健康 公平 卫生 公平
- 医学社会学 医学社会学
背景情况:
- 由于社会和系统障碍,代表性不足的少数群体 (URM) 在医学上仍然受到限制.
- 政策驱动者和现场努力尚未完全克服这些挑战.
- 需要进行现实的审查,以了解扩大访问 (WA) 的上下文-机制-结果-配置 (CMOCs).
研究的目的:
- 确定与扩大医学院入学机会相关的基础CMOC.
- 分析干预措施如何实现扩大获取和增加多样性.
- 了解环境在扩大访问倡议的有效性中的作用.
主要方法:
- 按照RAMESES标准进行现实主义文献综述.
- 在8个数据库中 (1990-2023) 搜索了关于扩大访问途径的研究.
- 采用现实的分析逻辑来检查干预,机制,结果和背景.
主要成果:
- 32项研究符合纳入标准,主要来自全球北方国家.
- 确定了五种类型的WA干预措施:最小化偏见,修改选择,社区协作,申请人准备和组合计划.
- 机制解决机构,情境或处置障碍;干预是系统或个人层面的.
结论:
- 目前扩大接入的干预措施主要针对个人 (情境,处置) 的障碍,而不是系统性问题.
- 这种焦点通过将申请人定位为需要改变的唯一元素来加强现状.
- 系统性和制度性障碍需要更多的关注,以有效地扩大医疗教育的机会.
相关概念视频
Introduction To Health Care Delivery System
4.8K
The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
4.8K
Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Drug Control Governance: Regulatory Bodies and Their Impact
706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
358
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
358


